Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
Microbiol Resour Announc ; 11(9): e0047822, 2022 Sep 15.
Article in English | MEDLINE | ID: mdl-35920671

ABSTRACT

Phage SN1 infects Sphaerotilus natans and Pseudomonas aeruginosa strains. Its genome consists of 61,858 bp (64.3% GC) and 89 genes, including 32 with predicted functions. SN1 genome is very similar to Pseudomonas phage M6, which contains hypermodified thymidines. Genome analyses revealed similar base-modifying genes as those found in M6.

3.
Am J Physiol Regul Integr Comp Physiol ; 306(11): R787-95, 2014 Jun 01.
Article in English | MEDLINE | ID: mdl-24647590

ABSTRACT

Sympathetic nervous system (SNS)-mediated peripheral vasoconstriction plays a key role in initial maintenance of blood pressure during rapid-onset asphyxia in the mammalian fetus, but it is attenuated after the first few minutes. It is unclear whether the SNS response is sustained during the brief, but frequently repeated, episodes of asphyxia characteristic of labor. In the present study, 14 fetal sheep at 0.85 of gestation received either chemical sympathectomy with 6-hydroxydopamine (6-OHDA; n = 7) or sham injection (control; n = 7), followed 4-5 days later by repeated 2-min episodes of complete umbilical cord occlusion every 5 min for up to 4 h or until mean arterial blood pressure (MAP) fell to <20 mmHg for two successive occlusions. In controls, umbilical cord occlusions were associated with a rapid initial fall in fetal heart rate (FHR) and femoral blood flow (FBF), with initial hypertension, followed by progressive development of hypotension during ongoing occlusions. Sympathectomy was associated with attenuation of the initial rise in MAP during umbilical cord occlusion, and after the onset of hypotension, a markedly more rapid fall of MAP to the nadir, with a correspondingly slower fall in FBF (P < 0.05). In contrast, MAP and FHR between successive occlusions were higher after sympathectomy (P < 0.05). There was no significant difference in the number of occlusions before terminal hypotension (6-OHDA; 16.1 ± 2.2 vs. control; 18.7 ± 2.3). These data show that SNS activity provides ongoing support for fetal MAP during prolonged exposure to brief repeated asphyxia.


Subject(s)
Blood Pressure/physiology , Fetus/physiology , Sympathetic Nervous System/physiology , Umbilical Arteries/physiopathology , Umbilical Cord/blood supply , Vasoconstriction/physiology , Animals , Asphyxia/physiopathology , Female , Heart Rate/physiology , Models, Animal , Oxidopamine/pharmacology , Pregnancy , Regional Blood Flow/physiology , Sheep , Sympathectomy, Chemical/methods , Sympathetic Nervous System/drug effects , Sympatholytics/pharmacology
4.
Am J Physiol Regul Integr Comp Physiol ; 304(10): R799-803, 2013 May 15.
Article in English | MEDLINE | ID: mdl-23485869

ABSTRACT

There is increasing evidence that exposure to infection can sensitize the fetus to subsequent hypoxic injury. However, it is unclear whether this involves compromise of the fetal cardiovascular adaptation to acute asphyxia. Chronically instrumented 103-day-old (0.7 gestational age, term is 147 days) fetal sheep in utero were randomized to receive either gram-negative lipopolysaccharide (LPS) as a continuous low-dose infusion for 120 h plus boluses of 1 µg LPS at 48, 72, and 96 h with asphyxia at 102 h (i.e., 6 h after the final LPS bolus) induced by umbilical cord occlusion for 15 min (LPS treated, n = 8), or the same volume of saline plus occlusion (saline treated, n = 7). Fetuses were killed 5 days after occlusion. LPS was associated with a more rapid fall in fetal heart rate at the onset of occlusion (P < 0.05) and with minimally lower values during occlusion (P < 0.05). The LPS-treated fetuses had lower fetal mean arterial blood pressure (BP) and greater carotid artery blood flow (CaBF) before occlusion (P < 0.05) but showed an increase in BP and fall in CaBF to similar values as saline controls during occlusion. There were no differences between the groups in femoral blood flow before or during occlusion. Contrary to our initial hypothesis, acute on chronic exposure to LPS was associated with more rapid cardiovascular adaptation to umbilical cord occlusion.


Subject(s)
Adaptation, Physiological/drug effects , Blood Pressure/drug effects , Lipopolysaccharides/pharmacology , Prenatal Exposure Delayed Effects/physiopathology , Reflex/drug effects , Regional Blood Flow/drug effects , Adaptation, Physiological/physiology , Animals , Asphyxia/physiopathology , Blood Pressure/physiology , Carotid Arteries/drug effects , Carotid Arteries/physiopathology , Endotoxins , Female , Fetus/blood supply , Fetus/physiopathology , Hypotension/physiopathology , Pregnancy , Regional Blood Flow/physiology , Sheep
6.
Am J Physiol Regul Integr Comp Physiol ; 304(3): R189-97, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23235324

ABSTRACT

Acute, high-dose exposure to endotoxin lipopolysaccharide (LPS) in preterm fetal sheep can trigger periventricular white matter lesions (PVL), in association with severe hypotension/hypoxemia and significant mortality. Intriguingly, however, chronic or repeated exposure to LPS can induce tachyphylaxis. We therefore tested the hypothesis that progressive, acute on chronic fetal infection would be associated with white matter injury with little fetal mortality. Chronically instrumented preterm (0.7 gestational age) fetal sheep were exposed to a continuous low-dose LPS infusion (100 ng over 24 h, followed by 250 ng/24 h for 96 h) or saline. Boluses of 1 µg LPS or saline were given at 48, 72, and 96 h; sheep were killed at day 10. Six of 11 fetal sheep exposed to saline infusion + LPS boluses died 4-7 h after the first bolus. In contrast, there was no fetal mortality after saline infusions alone (n = 9), low-dose LPS infusion + saline boluses (n = 5), or low-dose LPS + LPS boluses (n = 9). Low-dose LPS infusion + LPS boluses was associated with greater microglial induction than low-dose LPS + saline boluses but a similar area of periventricular white matter inflammation. One fetus developed severe focal white matter necrosis after LPS infusion + boluses. The acute cardiovascular compromise associated with high-dose, acute exposure to LPS is markedly attenuated by previous low-dose infusions, with limited apparent exacerbation of periventricular white matter injury compared with low-dose infusion alone.


Subject(s)
Brain/drug effects , Brain/physiopathology , Endotoxins/toxicity , Nerve Fibers, Myelinated/drug effects , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/physiopathology , Animals , Animals, Newborn , Dose-Response Relationship, Drug , Female , Male , Pregnancy , Premature Birth , Sheep , Survival Rate , Toxicity Tests, Acute , Toxicity Tests, Chronic
10.
Stroke ; 43(11): 3114-7, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22923445

ABSTRACT

BACKGROUND AND PURPOSE: Hypothermia induced after perinatal hypoxia-ischemia is partially protective. This study examined whether early treatment with the noncompetitive N-methyl-d-aspartate receptor antagonist, dizocilpine, can augment neuroprotection with delayed hypothermia after severe asphyxia in preterm fetal sheep at 0.7 weeks gestation (equivalent to 28-32 weeks in humans). METHODS: Fifty minutes after umbilical cord occlusion for 25 minutes, fetuses were randomized to either dizocilpine (2 mg/kg estimated fetal weight intravenously, then 0.07 mg/kg/h for 4 hours) and then after 5.5 hours to whole-body cooling to 3°C below baseline, or sham cooling, until 72 hours, and euthanized 7 days after umbilical cord occlusion. RESULTS: Delayed hypothermia was associated with improved neuronal survival (P<0.02) and reduced microglia (P=0.004) and caspase-3-positive cells (P<0.01) compared with umbilical cord occlusion. Dizocilpine was associated with reduced microglia (P<0.05) but no effect on caspase-3 induction and improved survival only in CA1/2 (P<0.05) with no apparent additive effect with delayed hypothermia. CONCLUSIONS: Early N-methyl-d-aspartate blockade and a clinical regime of delayed whole-body hypothermia provide nonadditive neuroprotection in the preterm brain.


Subject(s)
Dizocilpine Maleate/pharmacology , Hypothermia, Induced , Hypoxia-Ischemia, Brain/pathology , Neuroprotective Agents/pharmacology , Animals , Asphyxia/complications , Excitatory Amino Acid Antagonists/pharmacology , Fetus , Hypoxia-Ischemia, Brain/metabolism , Sheep
14.
Reprod Fertil Dev ; 23(5): 665-72, 2011.
Article in English | MEDLINE | ID: mdl-21635815

ABSTRACT

Maternal cortisol levels increase during pregnancy. Although this change is important for optimal fetal growth, the mechanisms of the changes in growth remain unclear. The hypothesis examined was that alterations in maternal plasma cortisol concentrations are associated with changes in the fetal insulin-like growth factor (IGF) axis. Pregnant ewes in late gestation (115 ± 0.4 days) were studied: six control animals, five ewes given 1 mg kg(-1) day(-1) cortisol (high cortisol) and five adrenalectomised ewes given 0.5-0.6 mg kg(-1) day(-1) cortisol (low cortisol). Blood samples were taken throughout the experiment and at necropsy (130 ± 0.2 days) and fetal liver was frozen for mRNA analysis. Fetal IGF-I and insulin plasma concentrations were lower and insulin-like growth factor-binding protein-1 (IGFBP-1) concentrations were higher in the low cortisol group compared with those in the control group (P < 0.05). Fetal liver IGF-II and IGFBP-3 mRNA were decreased in low cortisol animals compared with controls (P < 0.05). There were no significant changes in these parameters in the high cortisol group, and there were no changes in fetal liver IGF-I, growth hormone receptor, IGF-I receptor, IGF-II receptor, IGFBP-1 or IGFBP-2 mRNA levels between the groups. These data suggest that reduced fetal IGF availability contributes to reduced fetal growth when maternal cortisol secretion is impaired, but not during exposure to moderate increases in cortisol.


Subject(s)
Fetus/metabolism , Hydrocortisone/blood , Insulin-Like Growth Factor Binding Proteins/metabolism , Liver/metabolism , Signal Transduction , Somatomedins/metabolism , Adrenalectomy , Analysis of Variance , Animals , Female , Gene Expression Regulation, Developmental , Gestational Age , Hydrocortisone/administration & dosage , Infusions, Intravenous , Insulin-Like Growth Factor Binding Proteins/blood , Insulin-Like Growth Factor Binding Proteins/genetics , Liver/embryology , Pregnancy , RNA, Messenger/metabolism , Regression Analysis , Sheep , Somatomedins/genetics , Up-Regulation
15.
Fetal Diagn Ther ; 25(3): 304-13, 2009.
Article in English | MEDLINE | ID: mdl-19776593

ABSTRACT

OBJECTIVE: To develop a model to study the fetal effects of intrapleural infusion of OK-432 (Picibanil), a pleurodesis agent derived from killed Gram-positive streptococci. METHODS: OK-432 (0.1 mg, n = 5), or normal saline (n = 5) were infused over 20 min into the pleural space of chronically instrumented preterm fetal sheep at 0.7 gestation. Fetal physiological parameters, including breathing and nuchal activity were monitored in utero from 6 h before infusion until 12 h afterward, and fetuses were killed after 7 days recovery. RESULTS: OK-432 was associated with transient suppression of fetal EEG activity, breathing and body movements from 3-6 h after infusion. Hypotension and hypoxia did not occur. At postmortem, local pleural adhesions were seen around the site of OK-432 infusion but not in saline treated fetuses. CONCLUSIONS: Intrapleural administration of OK-432 is associated with marked but transient fetal behavioral effects. This model will enable preclinical investigation of the neural and cardiovascular safety of OK-432 at a clinical relevant stage of development.


Subject(s)
Fetus/drug effects , Picibanil/adverse effects , Sheep/physiology , Animals , Blood Pressure/drug effects , Chylothorax/drug therapy , Chylothorax/veterinary , Heart Rate, Fetal/drug effects , Picibanil/administration & dosage , Pleural Cavity/drug effects , Pleural Cavity/pathology , Respiration/drug effects
16.
Am J Physiol Regul Integr Comp Physiol ; 297(4): R998-R1008, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19641129

ABSTRACT

The efferent mechanisms mediating the well-known diurnal cardiovascular rhythms in the late-gestation fetus are only partially understood. In the present study, we evaluated the contribution of the parasympathetic and sympathetic nervous systems (SNS) to these rhythms. Chronically instrumented fetal sheep at a mean (SE) of 122 (1) days gestation (term is 147 days) underwent either chemical sympathectomy with 6-hydroxydopamine the day after surgery (n = 8), vagotomy at surgery (n = 8), or were sham controls (n = 8). Fetal heart rate (HR), fetal HR variability (HRV), mean arterial blood pressure (MAP), carotid blood flow (CaBF), electrocorticogram (ECoG) activity, and nuchal activity were measured continuously for 24 h. Changes between sleep states were determined in a 6-h interval. Control fetal sheep showed consistent diurnal rhythms in fetal HR, HRV, MAP, and CaBF, with maximal activity in the evening, but not in nuchal activity. Sympathectomy was associated with a significant reduction of both fetal HR and HRV, while vagotomy was associated with a fall in fetal HRV (P < 0.05) but no change in HR. Despite this, most animals in the two intervention groups still showed diurnal rhythms for fetal HR, HRV, MAP, and CaBF, although peak HR may have been delayed in the sympathectomy group (mean 02:22 vs. 23:54 h in controls, P = 0.06). There was no effect of either intervention on sleep state cycling, although state-related cardiovascular rhythms were significantly modulated. These data indicate that, neither the SNS nor vagal activity, in isolation at least, is essential for generating cardiovascular diurnal rhythms in the late-gestation fetus.


Subject(s)
Circadian Rhythm , Fetus/innervation , Hemodynamics , Sleep , Sympathetic Nervous System/embryology , Vagus Nerve/embryology , Animals , Biomarkers/blood , Blood Pressure , Carotid Arteries/embryology , Carotid Arteries/innervation , Circadian Rhythm/drug effects , Electrocardiography , Electroencephalography , Electromyography , Female , Fetal Blood/metabolism , Fetal Heart/innervation , Gestational Age , Heart Rate, Fetal , Hemodynamics/drug effects , Oxidopamine/pharmacology , Pregnancy , Regional Blood Flow , Sheep , Sympathectomy, Chemical/methods , Sympathetic Nervous System/drug effects , Sympatholytics/pharmacology , Vagotomy , Vagus Nerve/surgery
17.
Clin Exp Pharmacol Physiol ; 35(11): 1316-20, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18671718

ABSTRACT

1. Adenosine A(1) receptor activation is critical for endogenous neuroprotection from hypoxia-ischaemia, raising the possibility that treatment with A(1) receptor agonists may be an effective physiological protection strategy for vulnerable preterm infants. However, the A(1) receptor can mediate unwanted systemic effects, including vasoconstriction of the afferent glomerular arteriole. There is limited information on whether this occurs at doses that improve cerebral perfusion in the immature brain. 2. Therefore, in the present study, we examined whether infusion of the selective A(1) receptor agonist adenosine amine congener (ADAC) is associated with reduced renal perfusion in chronically instrumented preterm (0.7 gestation) fetal sheep. In the present study, ADAC was given in successive doses of 2.5, 5.0 and 15.0 microg, 45 min apart. 3. Treatment with ADAC was associated with a marked reduction in renal vascular conductance (and blood flow), whereas carotid conductance was increased and there was no significant effect on femoral conductance. In contrast with the stable effects of increasing ADAC dose on vascular conductance, there was a significant dose-related fall in fetal heart rate and blood pressure. 4. In conclusion, these short-term data support the concern that A(1) receptor agonist infusion can selectively impair renal perfusion, even at low doses.


Subject(s)
Adenosine/analogs & derivatives , Carotid Arteries/drug effects , Femoral Artery/drug effects , Fetus/blood supply , Fetus/drug effects , Renal Circulation/drug effects , Adenosine/pharmacology , Adenosine/therapeutic use , Animals , Carotid Arteries/physiology , Female , Femoral Artery/physiology , Pregnancy , Premature Birth/drug therapy , Premature Birth/physiopathology , Regional Blood Flow/drug effects , Regional Blood Flow/physiology , Renal Circulation/physiology , Sheep, Domestic
18.
J Appl Physiol (1985) ; 103(4): 1311-7, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17656627

ABSTRACT

There is evidence that preterm fetuses have blunted chemoreflex-mediated responses to hypoxia. However, the preterm fetus has much lower aerobic requirements than at term, and so moderate hypoxia may not be sufficient to elicit maximal chemoreflex responses; there are only limited quantitative data on the ontogeny of chemoreflex and hemodynamic responses to severe asphyxia. Chronically instrumented fetal sheep at 0.6 (n = 12), 0.7 (n = 12), and 0.85 (n = 8) of gestational age (GA; term = 147 days) were exposed to 30, 25, or 15 min of complete umbilical cord occlusion, respectively. At all ages, occlusion was associated with early onset of bradycardia, profoundly reduced femoral blood flow and conductance, and hypertension. The 0.6-GA fetuses showed a significantly slower and lesser fall in femoral blood flow and conductance compared with the 0.85-GA group, with a correspondingly reduced relative rise in mean arterial blood pressure. As occlusion continued, the initial adaptation was followed by loss of peripheral vasoconstriction and progressive development of hypotension in all groups. The 0.85-GA fetuses showed significantly more sustained reduction in femoral conductance but also more rapid onset of hypotension than either of the younger groups. Electroencephalographic (EEG) activity was suppressed during occlusion in all groups, but the degree of suppression was less at 0.6 GA than at term. In conclusion, the near-midgestation fetus shows attenuated initial (chemoreflex) peripheral vasomotor responses to severe asphyxia compared with more mature fetuses but more sustained hemodynamic adaptation and reduced suppression of EEG activity during continued occlusion of the umbilical cord.


Subject(s)
Blood Pressure/physiology , Fetal Hypoxia/physiopathology , Heart Rate, Fetal/physiology , Sheep/physiology , Umbilical Cord/blood supply , Adaptation, Physiological , Animals , Balloon Occlusion , Chemoreceptor Cells/physiopathology , Disease Models, Animal , Femoral Artery/physiopathology , Fetal Hypoxia/etiology , Fetus , Gestational Age , Hypotension/etiology , Hypotension/physiopathology , Regional Blood Flow/physiology , Time Factors , Umbilical Cord/physiopathology , Umbilical Cord/surgery
19.
Am J Physiol Regul Integr Comp Physiol ; 292(4): R1569-76, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17170231

ABSTRACT

The preterm fetus is capable of surviving prolonged periods of severe hypoxia without neural injury for much longer than at term. To evaluate the hypothesis that regulated suppression of brain metabolism contributes to this remarkable tolerance, we assessed changes in the redox state of cytochrome oxidase (CytOx) relative to cerebral heat production, and cytotoxic edema measured using cerebral impedance, during 25 min of complete umbilical cord occlusion or sham occlusion in fetal sheep at 0.7 gestation. Occlusion was followed by rapid, profound reduction in relative cerebral oxygenation and EEG intensity and an immediate increase in oxidized CytOx, indicating a reduction in electron flow down the mitochondrial electron transfer chain. Confirming rapid suppression of cerebral metabolism there was a loss of the temperature difference between parietal cortex and body at a time when carotid blood flow was maintained at control values. As occlusion continued, severe hypotension/hypoperfusion developed, with a further increase in CytOx levels to a plateau between 8 and 13 min and a progressive rise in cerebral impedance. In conclusion, these data strongly suggest active regulation of cerebral metabolism during the initial response to severe hypoxia, which may help to protect the immature brain from injury.


Subject(s)
Electron Transport Complex IV/metabolism , Umbilical Cord/physiopathology , Animals , Blood Glucose/metabolism , Brain/metabolism , Carbon Dioxide/blood , Carotid Arteries/metabolism , Cerebral Cortex/blood supply , Edema , Electric Impedance , Electroencephalography , Female , Fetal Hypoxia/metabolism , Fetal Hypoxia/pathology , Fetal Hypoxia/physiopathology , Gestational Age , Hydrogen-Ion Concentration , Lactic Acid/blood , Oxidation-Reduction , Oxygen/blood , Pregnancy , Sheep/embryology , Thermogenesis , Time Factors
20.
Genome ; 49(4): 346-53, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16699554

ABSTRACT

Candida albicans is a diploid fungus that undergoes a morphological transition between budding yeast, hyphal, and pseudohyphal forms. The morphological transition is strongly correlated with virulence and is regulated in part by quorum sensing. Candida albicans produces and secretes farnesol that regulates the yeast to mycelia morphological transition. Mutants that fail to synthesize or respond to farnesol could be locked in the filamentous mode. To test this hypothesis, a collection of C. albicans mutants were isolated that have altered colony morphologies indicative of the presence of hyphal cells under environmental conditions where C. albicans normally grows only as yeasts. All mutants were characterized for their ability to respond to farnesol. Of these, 95.9% fully or partially reverted to wild-type morphology on yeast malt (YM) agar plates supplemented with farnesol. All mutants that respond to farnesol regained their hyphal morphology when restreaked on YM plates without farnesol. The observation that farnesol remedial mutants are so common (95.9%) relative to mutants that fail to respond to farnesol (4.1%) suggests that farnesol activates and (or) induces a pathway that can override many of the morphogenesis defects in these mutants. Additionally, 9 mutants chosen at random were screened for farnesol production. Two mutants failed to produce detectable levels of farnesol.


Subject(s)
Candida albicans/physiology , Farnesol/metabolism , Genetic Variation , Mutagens/pharmacology , Candida albicans/growth & development , Candida albicans/isolation & purification , Ethyl Methanesulfonate/pharmacology , Hyphae/drug effects , Hyphae/growth & development , Nitrous Acid/pharmacology , Stem Cells/drug effects , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...